A Study Evaluating Efficacy Of Tolvaptan With Cell-Free and Concentrated Reinfusion Therapy (CART) For The Treatment Of Refractory Hepatic Ascites In Patients With Decompensated Liver Cirrhosis.
Phase of Trial: Phase IV
Latest Information Update: 05 Jan 2017
At a glance
- Drugs Tolvaptan (Primary)
- Indications Ascites
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 05 Jan 2017 New trial record